Evotec SE SEC filings EVOTF

Evotec SE has 190 filings in SEC EDGAR's recent list, going back to Sep 19, 2007. Its latest annual report, Form 20-F, was filed on Apr 8, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 5, 2026. The company's fiscal year ends on December 31.

Form Description Filed Period
S-8 Employee stock plan registration May 30, 2023 —
S-8 Employee stock plan registration Nov 9, 2021 —
424B4 Prospectus Nov 5, 2021 —
F-1/A Filing Oct 29, 2021 —
F-1/A Filing Oct 28, 2021 —
F-1/A Filing Oct 26, 2021 —
F-1/A Filing Oct 22, 2021 —
F-1 Registration statement (foreign issuer) Oct 8, 2021 —
F-6 POS Filing Dec 30, 2010 —
S-8 POS Post-effective amendment no. 1 to form s-8 Dec 30, 2010 —
S-8 Employee stock plan registration May 6, 2008 —
F-4/A Amendment no. 4 to form f-4 Mar 21, 2008 —
F-4/A Amendment no.3 to form f-4 Mar 12, 2008 —
F-4/A Amendment no. 2 to form f-4 Mar 11, 2008 —
F-4/A Amendment no. 1 to form f-4 Feb 20, 2008 —
F-6 Filing Jan 11, 2008 —
F-4 Form f-4 Jan 7, 2008 —

Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
EVO (Nasdaq), EVOTF (OTC)
Fiscal year ends
December 31
Incorporated in
Germany
Headquarters
Hamburg
SEC filer status
Large accelerated filer
SEC CIK
1412558
Former names
Evotec AG (until Sep 23, 2021)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.